Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
11.18
-0.04 (-0.36%)
Sep 25, 2026, 4:00 PM EDT - Market closed
Silence Therapeutics Employees
Silence Therapeutics had 88 employees as of December 31, 2025. The number of employees decreased by 28 or -24.14% compared to the previous year.
Employees
88
Change (1Y)
-28
Growth (1Y)
-24.14%
Revenue / Employee
$6,989
Profits / Employee
-$681,284
Market Cap
673.14M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 88 | -28 | -24.14% |
| Dec 31, 2024 | 116 | 7 | 6.42% |
| Dec 31, 2023 | 109 | -13 | -10.66% |
| Dec 31, 2022 | 122 | 17 | 16.19% |
| Dec 31, 2021 | 105 | 40 | 61.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| MiMedx Group | 808 |
| Ginkgo Bioworks Holdings | 485 |
| DBV Technologies | 170 |
| Aura Biosciences | 113 |
| Verastem | 102 |
| Annexon | 92 |
| OmniAb | 89 |
| Zevra Therapeutics | 61 |
SLN News
- 10 days ago - Silence Therapeutics Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 11 days ago - Silence Therapeutics Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 17 days ago - Silence Therapeutics Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 23 days ago - Silence Therapeutics Slides: Corporate presentation - Filings
- 24 days ago - Silence Therapeutics to Participate in Three September Investor Conferences - Business Wire
- 5 weeks ago - Silence Therapeutics 13M share Secondary priced at $13.50 - TheFly
- 5 weeks ago - Silence Therapeutics 13M share Secondary priced at $13.50 - TheFly
- 6 weeks ago - Silence Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters' Option to Purchase Additional ADSs - Business Wire